190 related articles for article (PubMed ID: 11085543)
21. Role of the ATPase domain of the Cockayne syndrome group B protein in UV induced apoptosis.
Balajee AS; Proietti De Santis L; Brosh RM; Selzer R; Bohr VA
Oncogene; 2000 Jan; 19(4):477-89. PubMed ID: 10698517
[TBL] [Abstract][Full Text] [Related]
22. The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression.
Grand RJ; Lecane PS; Owen D; Grant ML; Roberts S; Levine AJ; Gallimore PH
Virology; 1995 Jul; 210(2):323-34. PubMed ID: 7618270
[TBL] [Abstract][Full Text] [Related]
23. Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.
Zacharatos PV; Gorgoulis VG; Kotsinas A; Manolis EN; Liloglou T; Rassidakis AN; Kanavaros P; Field JD; Halazonetis T; Kittas C
Anticancer Res; 1999; 19(1A):579-87. PubMed ID: 10226602
[TBL] [Abstract][Full Text] [Related]
24. Discordance between accumulated p53 protein level and its transcriptional activity in response to u.v. radiation.
Lu X; Burbidge SA; Griffin S; Smith HM
Oncogene; 1996 Jul; 13(2):413-8. PubMed ID: 8710381
[TBL] [Abstract][Full Text] [Related]
25. Differences in mutant p53 protein stability and functional activity in teniposide-sensitive and -resistant human leukemic CEM cells.
Morgan SE; Kim R; Wang PC; Bhat UG; Kusumoto H; Lu T; Beck WT
Oncogene; 2000 Oct; 19(43):5010-9. PubMed ID: 11042688
[TBL] [Abstract][Full Text] [Related]
26. Dissection of transcriptional and non-transcriptional p53 activities in the response to genotoxic stress.
Speidel D; Helmbold H; Deppert W
Oncogene; 2006 Feb; 25(6):940-53. PubMed ID: 16247471
[TBL] [Abstract][Full Text] [Related]
27. Increased apoptosis induction by 121F mutant p53.
Saller E; Tom E; Brunori M; Otter M; Estreicher A; Mack DH; Iggo R
EMBO J; 1999 Aug; 18(16):4424-37. PubMed ID: 10449408
[TBL] [Abstract][Full Text] [Related]
28. A truncated isoform of the PP2A B56gamma regulatory subunit reduces irradiation-induced Mdm2 phosphorylation and could contribute to metastatic melanoma cell radioresistance.
Koma YI; Ito A; Watabe K; Kimura SH; Kitamura Y
Histol Histopathol; 2004 Apr; 19(2):391-400. PubMed ID: 15024700
[TBL] [Abstract][Full Text] [Related]
29. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
Piovesan B; Pennell N; Berinstein NL
Oncogene; 1998 Nov; 17(18):2339-50. PubMed ID: 9811465
[TBL] [Abstract][Full Text] [Related]
30. Aberrant p21 regulation in radioresistant primary glioblastoma multiforme cells bearing wild-type p53.
Kraus A; Gross MW; Knuechel R; Münkel K; Neff F; Schlegel J
J Neurosurg; 2000 Nov; 93(5):863-72. PubMed ID: 11059670
[TBL] [Abstract][Full Text] [Related]
31. Regulation of P53 stability in p53 mutated human and mouse hepatoma cells.
Hailfinger S; Jaworski M; Marx-Stoelting P; Wanke I; Schwarz M
Int J Cancer; 2007 Apr; 120(7):1459-64. PubMed ID: 17205518
[TBL] [Abstract][Full Text] [Related]
32. Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice.
Bouvard V; Zaitchouk T; Vacher M; Duthu A; Canivet M; Choisy-Rossi C; Nieruchalski M; May E
Oncogene; 2000 Feb; 19(5):649-60. PubMed ID: 10698510
[TBL] [Abstract][Full Text] [Related]
33. MDMX: a novel p53-binding protein with some functional properties of MDM2.
Shvarts A; Steegenga WT; Riteco N; van Laar T; Dekker P; Bazuine M; van Ham RC; van der Houven van Oordt W; Hateboer G; van der Eb AJ; Jochemsen AG
EMBO J; 1996 Oct; 15(19):5349-57. PubMed ID: 8895579
[TBL] [Abstract][Full Text] [Related]
34. Poly(ADP-ribosyl)ation is required for p53-dependent signal transduction induced by radiation.
Wang X; Ohnishi K; Takahashi A; Ohnishi T
Oncogene; 1998 Dec; 17(22):2819-25. PubMed ID: 9879988
[TBL] [Abstract][Full Text] [Related]
35. Impaired p53 expression, function, and nuclear localization in calreticulin-deficient cells.
Mesaeli N; Phillipson C
Mol Biol Cell; 2004 Apr; 15(4):1862-70. PubMed ID: 14767071
[TBL] [Abstract][Full Text] [Related]
36. The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo.
Reinke V; Lozano G
Oncogene; 1997 Sep; 15(13):1527-34. PubMed ID: 9380404
[TBL] [Abstract][Full Text] [Related]
37. The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract.
Sheikh MS; Huang Y; Fernandez-Salas EA; El-Deiry WS; Friess H; Amundson S; Yin J; Meltzer SJ; Holbrook NJ; Fornace AJ
Oncogene; 1999 Jul; 18(28):4153-9. PubMed ID: 10435597
[TBL] [Abstract][Full Text] [Related]
38. Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop.
Arriola EL; Lopez AR; Chresta CM
Oncogene; 1999 Jan; 18(4):1081-91. PubMed ID: 10023685
[TBL] [Abstract][Full Text] [Related]
39. Functions of the MDM2 oncoprotein.
Freedman DA; Wu L; Levine AJ
Cell Mol Life Sci; 1999 Jan; 55(1):96-107. PubMed ID: 10065155
[TBL] [Abstract][Full Text] [Related]
40. p53 regulation and function in renal cell carcinoma.
Warburton HE; Brady M; Vlatković N; Linehan WM; Parsons K; Boyd MT
Cancer Res; 2005 Aug; 65(15):6498-503. PubMed ID: 16061625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]